Petros Pharmaceuticals Announces Pricing of $9.6 Million Public Offering of Common Stock and Warrants [Yahoo! Finance]
Petros Pharmaceuticals, Inc. (PTPI)
Company Research
Source: Yahoo! Finance
Tue, February 18, 2025 at 3:25 PM GMT+1 5 min read In This Article PTPI NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over-the-counter ("OTC") drug development programs, today announces the pricing of a public offering of approximately 40,000,000 shares of the Company's common stock ("Common Stock"), par value $0.0001 per share (or pre-funded warrants in lieu thereof), with each share of Common Stock (or pre-funded warrant) accompanied by (i) a Series A Warrant to purchase 0.25 share of Common Stock at an exercise price of $0.48 per 0.25 share ("Series A Warrant") and (ii) a
Read more
Impact Snapshot
Event Time:
PTPI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PTPI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PTPI alerts
High impacting Petros Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
PTPI
News
- Petros Pharmaceuticals files to sell units, no amount given [Seeking Alpha]Seeking Alpha
- Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final RulesAccesswire
- Petros Pharmaceuticals Featured in “New Era of Healthcare, AI, Data and Consumer Empowerment” [Yahoo! Finance]Yahoo! Finance
- Petros Pharmaceuticals Featured in “New Era of Healthcare, AI, Data and Consumer Empowerment”Accesswire
- Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at over $38 Billion annuallyAccesswire
PTPI
Sec Filings
- 3/7/25 - Form PRE
- 2/26/25 - Form SCHEDULE
- 2/21/25 - Form 4
- PTPI's page on the SEC website